John Hohneker, M.D.
Board Member
ArriVent BioPharma, Inc. (AVBP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Hohneker, M.D.
John Hohneker, M.D. is recorded as Board Member at ArriVent BioPharma, Inc. (AVBP). ArriVent BioPharma, Inc. reported in an 8-K filed May 16, 2024 that John Hohneker, M.D. was appointed Class II Director, effective May 16, 2024.
“On May 16, 2024, the Board of Directors (the "Board") of ArriVent BioPharma, Inc. (the "Company") appointed John Hohneker, M.D., to the Board, effective as of May 16, 2024 (the "Effective Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ArriVent BioPharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Winston Kung CFO
- Robin LaChapelle COO
- James Kastenmayer General Counsel
- Chris W. Nolet Board Member
- James Healy Board Member
- John Hohneker Board Member
- Kristine Peterson Board Member
- Merdad Parsey Board Member
- Merdad Parsey, M.D., Ph.D. Board Member
- Stuart Lutzker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.